Page last updated: 2024-08-17

quinoxalines and dinoprostone

quinoxalines has been researched along with dinoprostone in 26 studies

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (30.77)18.2507
2000's13 (50.00)29.6817
2010's4 (15.38)24.3611
2020's1 (3.85)2.80

Authors

AuthorsStudies
Bourne, HR; Conklin, BR; Wong, YH1
Kilfeather, S; O'Malley, K; Stein, M1
Dachicourt, N; Gangnerau, MN; Giroix, MH; Portha, B; Serradas, P1
Díaz-Cazorla, M; Jiménez, W; Lamas, S; Pérez-Sala, D; Ros, J1
Bouscarel, B; Ceryak, S; DeFabo, EC; Gettys, TW; Noonan, F; Phillips, TM1
Li, L; Paakkari, I; Vaali, K; Vapaatalo, H1
Aley, KO; Levine, JD; McCarter, G1
Cunha, FQ; Ferreira, SH; Teixeira, MM1
Liu, XD; Rennard, SI; Romberger, DJ; Skold, CM; Spurzem, JR; Umino, T1
Ignatowski, TA; Kunkel, SL; Spengler, RN1
Duarte, ID; Ferreira, SH1
Randich, A; Turnbach, ME1
Ferreira, SH; Parada, CA; Vivancos, GG1
Cunha, FQ; Ferreira, SH; Sachs, D1
Cury, Y; Picolo, G1
Chang, PR; Chen, YJ; Huang, HC; Huang, YT; Kuo, YR; Sun, YC; Wang, CJ; Wang, FS; Yang, KD; Yang, YJ1
Brito, GA; Cunha, FQ; Ferreira, SH; Lotufo, CM; Ribeiro, RA; Sachs, D; Vale, ML1
Fu, WM; Jeng, KC; Kuo, SC; Lee, FY; Liou, HC; Lu, DY; Tang, CH; Teng, CM1
Dunkern, TR; Feurstein, D; Hatzelmann, A; Rossi, GA; Sabatini, F1
Cunha, FQ; Duarte, DB; Ferrari, LF; Ferreira, SH; Funez, MI; Lorenzetti, BB; Parada, CA; Sachs, D1
Cheevers, CV; Donello, JE; Gil, DW; Kedzie, KM; Manlapaz, CA; Rao, S; Tang, E1
Côrtes, SF; Duarte, ID; Galdino, GS; Perez, AC; Resende, LC; Romero, TR; Silva, GC1
Barbosa, AL; Moraes, MO; Oliveira, GJ; Pinheiro, CA; Ribeiro, RA; Souza, MH; Torres, JN; Vale, ML1
Araldi, D; Ferrari, LF; Ferreira, SH; Lotufo, CM; Macedo, LP; Parada, CA; Rodrigues, MA1
Goto, S; Haji, A; Kimura, S; Miyazawa, K; Mizutani, Y; Ohi, Y1
Antczak, MI; Dawson, D; Desai, AB; Fink, S; Geboers, S; Hu, B; Li, H; Markowitz, SD; Nishikawa, G; Ready, JM; Smith, J; Toda, K; Wang, X; Williams, NS1

Other Studies

26 other study(ies) available for quinoxalines and dinoprostone

ArticleYear
Gz-mediated hormonal inhibition of cyclic AMP accumulation.
    Science (New York, N.Y.), 1992, Jan-17, Volume: 255, Issue:5042

    Topics: Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Chorionic Gonadotropin; Colforsin; Cyclic AMP; Dinoprostone; Dopamine; Gene Expression Regulation; GTP-Binding Proteins; Hormones; In Vitro Techniques; Lysophospholipids; Pertussis Toxin; Quinoxalines; Rats; Signal Transduction; Transfection; Virulence Factors, Bordetella

1992
Ethnic differences in cyclic AMP accumulation: effect on alpha 2, beta 2, and prostanoid receptor responses.
    Clinical pharmacology and therapeutics, 1990, Volume: 47, Issue:3

    Topics: Adult; Basal Metabolism; Black People; Blood Platelets; Brimonidine Tartrate; Cyclic AMP; Dinoprostone; Female; Humans; Isoproterenol; Lymphocytes; Male; Quinoxalines; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Stimulation, Chemical; White People

1990
Decreased glucose-induced cAMP and insulin release in islets of diabetic rats: reversal by IBMX, glucagon, GIP.
    The American journal of physiology, 1996, Volume: 271, Issue:4 Pt 1

    Topics: 1-Methyl-3-isobutylxanthine; Adenylyl Cyclases; Animals; Brimonidine Tartrate; Cyclic AMP; Diabetes Mellitus, Experimental; Dinoprostone; Galanin; Gastric Inhibitory Polypeptide; Glucagon; Insulin; Insulin Secretion; Islets of Langerhans; Quinoxalines; Rats; Rats, Wistar; Secretory Rate; Somatostatin

1996
Tetrahydrobiopterin modulates cyclooxygenase-2 expression in human mesangial cells.
    Biochemical and biophysical research communications, 1997, Dec-08, Volume: 241, Issue:1

    Topics: Biopterins; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Drug Synergism; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Glomerular Mesangium; Humans; Interleukin-1; Isoenzymes; Membrane Proteins; Methotrexate; NG-Nitroarginine Methyl Ester; Oxadiazoles; Prostaglandin-Endoperoxide Synthases; Pteridines; Pterins; Quinoxalines; Recombinant Proteins; RNA, Messenger; Transcription, Genetic; Tumor Necrosis Factor-alpha

1997
Regulation of stimulated cyclic AMP synthesis by urocanic acid.
    Photochemistry and photobiology, 1998, Volume: 67, Issue:3

    Topics: Adrenergic alpha-Agonists; Alprostadil; Animals; Brimonidine Tartrate; Cells, Cultured; Colon; Cricetinae; Cyclic AMP; Dinoprostone; Epinephrine; Fibroblasts; Histamine; HT29 Cells; Humans; Liver; Mesocricetus; Quinoxalines; Urocanic Acid

1998
Involvement of bradykinin B1 and B2 receptors in relaxation of mouse isolated trachea.
    British journal of pharmacology, 1998, Volume: 123, Issue:7

    Topics: Animals; Bradykinin; Bradykinin Receptor Antagonists; Dinoprostone; Enzyme Inhibitors; Female; Guanylate Cyclase; In Vitro Techniques; Indomethacin; Male; Mice; Mice, Inbred BALB C; Muscle Relaxation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Nitroprusside; Oxadiazoles; Prostaglandin-Endoperoxide Synthases; Quinoxalines; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Receptors, Bradykinin; Trachea

1998
Nitric oxide signaling in pain and nociceptor sensitization in the rat.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1998, Sep-01, Volume: 18, Issue:17

    Topics: Animals; Dinoprostone; Enzyme Inhibitors; Guanylate Cyclase; Hyperalgesia; Male; Nitric Oxide; Nitric Oxide Synthase; Nociceptors; omega-N-Methylarginine; Oxadiazoles; Pain; Quinoxalines; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Signal Transduction; Tetrodotoxin

1998
Pharmacological modulation of secondary mediator systems--cyclic AMP and cyclic GMP--on inflammatory hyperalgesia.
    British journal of pharmacology, 1999, Volume: 127, Issue:3

    Topics: Animals; Bradykinin; Carrageenan; Cyclic AMP; Cyclic GMP; Dinoprostone; Dopamine; Hyperalgesia; Inflammation; Interleukin-1; Interleukin-6; Interleukin-8; Isoquinolines; Male; Oxadiazoles; Phosphodiesterase Inhibitors; Pyrrolidinones; Quinoxalines; Rats; Rats, Wistar; Rolipram; Second Messenger Systems; Sulfonamides; Tumor Necrosis Factor-alpha

1999
Sodium nitroprusside augments human lung fibroblast collagen gel contraction independently of NO-cGMP pathway.
    American journal of physiology. Lung cellular and molecular physiology, 2000, Volume: 278, Issue:5

    Topics: Animals; Cell Line; Collagen; Cyclic GMP; Dinoprostone; Enzyme Inhibitors; Fetus; Fibroblasts; Fibronectins; Gels; Humans; Lung; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Nitroso Compounds; Oxadiazoles; Penicillamine; Platelet Aggregation Inhibitors; Quinoxalines; Rats; Thionucleotides; Vasodilator Agents

2000
Interactions between the alpha(2)-adrenergic and the prostaglandin response in the regulation of macrophage-derived tumor necrosis factor.
    Clinical immunology (Orlando, Fla.), 2000, Volume: 96, Issue:1

    Topics: Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Cells, Cultured; Dinoprostone; Dose-Response Relationship, Drug; Female; Lipopolysaccharides; Macrophages, Peritoneal; Mice; Mice, Inbred CBA; Quinoxalines; Receptors, Adrenergic, alpha-2; RNA, Messenger; Tumor Necrosis Factor-alpha

2000
L-NAME causes antinociception by stimulation of the arginine-NO-cGMP pathway.
    Mediators of inflammation, 2000, Volume: 9, Issue:1

    Topics: Analgesics; Animals; Arginine; Carrageenan; Cyclic GMP; Dinoprostone; Hyperalgesia; Male; Methylene Blue; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Oxadiazoles; Phosphodiesterase Inhibitors; Phthalazines; Quinoxalines; Rats; Rats, Wistar; Signal Transduction

2000
The role of spinal neurokinin-1 and glutamate receptors in hyperalgesia and allodynia induced by prostaglandin E(2) or zymosan in the rat.
    Pain, 2002, Volume: 97, Issue:1-2

    Topics: 2-Amino-5-phosphonovalerate; Alanine; Animals; Dinoprostone; Excitatory Amino Acid Antagonists; Hyperalgesia; Male; Neurokinin-1 Receptor Antagonists; Piperidines; Quinoxalines; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Glutamate; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Receptors, Neurokinin-1; Spinal Cord; Zymosan

2002
Opposite nociceptive effects of the arginine/NO/cGMP pathway stimulation in dermal and subcutaneous tissues.
    British journal of pharmacology, 2003, Volume: 138, Issue:7

    Topics: Animals; Arginine; Bucladesine; Cyclic GMP; Dermis; Dinoprostone; Dose-Response Relationship, Drug; Hyperalgesia; Injections, Subcutaneous; Male; Molsidomine; Nitric Oxide; Nociceptors; omega-N-Methylarginine; Oxadiazoles; Pain Measurement; Quinoxalines; Rats; Rats, Wistar; Subcutaneous Tissue; Time Factors

2003
Peripheral analgesic blockade of hypernociception: activation of arginine/NO/cGMP/protein kinase G/ATP-sensitive K+ channel pathway.
    Proceedings of the National Academy of Sciences of the United States of America, 2004, Mar-09, Volume: 101, Issue:10

    Topics: Adenosine Triphosphate; Analgesics; Animals; Arginine; Carbazoles; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Dinoprostone; Indoles; Male; Nitric Oxide; Nociceptors; omega-N-Methylarginine; Oxadiazoles; Potassium Channels; Quinoxalines; Rats; Rats, Wistar; Signal Transduction

2004
Peripheral neuronal nitric oxide synthase activity mediates the antinociceptive effect of Crotalus durissus terrificus snake venom, a delta- and kappa-opioid receptor agonist.
    Life sciences, 2004, Jun-18, Volume: 75, Issue:5

    Topics: Analgesics; Animals; Crotalid Venoms; Crotalus; Dinoprostone; Drug Antagonism; Enzyme Inhibitors; Hyperalgesia; Indazoles; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Oxadiazoles; Quinoxalines; Rats; Rats, Wistar; Receptors, Opioid, delta; Receptors, Opioid, kappa

2004
Nitric oxide mediates ultrasound-induced hypoxia-inducible factor-1alpha activation and vascular endothelial growth factor-A expression in human osteoblasts.
    Bone, 2004, Volume: 35, Issue:1

    Topics: Calcium; Cell Line; Dinoprostone; Endothelial Cells; Guanylate Cyclase; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Osteoblasts; Oxadiazoles; Quinoxalines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factors; Transcription, Genetic; Ultrasonics; Vascular Endothelial Growth Factor A

2004
Peripheral antinociceptive effect of pertussis toxin: activation of the arginine/NO/cGMP/PKG/ ATP-sensitive K channel pathway.
    The European journal of neuroscience, 2006, Volume: 24, Issue:4

    Topics: Adenosine Triphosphate; Analgesia; Analgesics; Animals; Arginine; Bucladesine; Carbazoles; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Dinoprostone; Enzyme Inhibitors; Ganglia, Spinal; Glyburide; Indoles; KATP Channels; Male; Neurons; Nitric Oxide; omega-N-Methylarginine; Oxadiazoles; Pain; Pain Measurement; Pertussis Toxin; Potassium Channels, Inwardly Rectifying; Quinoxalines; Rats; Rats, Wistar; Signal Transduction; Tolbutamide

2006
YC-1 attenuates LPS-induced proinflammatory responses and activation of nuclear factor-kappaB in microglia.
    British journal of pharmacology, 2007, Volume: 151, Issue:3

    Topics: Animals; Blotting, Western; Cell Line; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Activators; Gene Expression; Guanylate Cyclase; Indazoles; Lipopolysaccharides; Luciferases; Microglia; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Oxadiazoles; Proline; Quinoxalines; Rats; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiocarbamates; Thionucleotides

2007
Inhibition of TGF-beta induced lung fibroblast to myofibroblast conversion by phosphodiesterase inhibiting drugs and activators of soluble guanylyl cyclase.
    European journal of pharmacology, 2007, Oct-15, Volume: 572, Issue:1

    Topics: Actins; Benzamides; Benzoates; Blotting, Western; Cell Differentiation; Cells, Cultured; Cyclic GMP; Dinoprostone; Drug Synergism; Enzyme Activators; Fibroblasts; Fibrosis; Guanylate Cyclase; Humans; Immunohistochemistry; Isoenzymes; Lung; Myocytes, Smooth Muscle; Natriuretic Peptide, Brain; Nitric Oxide Donors; Nitroso Compounds; Oxadiazoles; Phosphodiesterase Inhibitors; Piperazines; Purines; Pyridines; Quinoxalines; Receptors, Cytoplasmic and Nuclear; Sildenafil Citrate; Soluble Guanylyl Cyclase; Sulfones; Transforming Growth Factor beta

2007
Teleantagonism: A pharmacodynamic property of the primary nociceptive neuron.
    Proceedings of the National Academy of Sciences of the United States of America, 2008, Dec-09, Volume: 105, Issue:49

    Topics: Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dinoprostone; Dopamine; Drug Interactions; Enzyme Inhibitors; Indomethacin; Interleukin-1beta; Male; Morphine; Naloxone; Narcotic Antagonists; Nitric Oxide; Nociceptors; omega-N-Methylarginine; Oxadiazoles; Pain; Pyrrolidines; Quinoxalines; Rats; Rats, Wistar; Sensory Receptor Cells; Signal Transduction

2008
Alpha-1-adrenergic receptor agonist activity of clinical alpha-adrenergic receptor agonists interferes with alpha-2-mediated analgesia.
    Anesthesiology, 2009, Volume: 110, Issue:2

    Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Analgesics; Animals; Brimonidine Tartrate; Calcium; Clonidine; Dinoprostone; Drug Interactions; Excitatory Amino Acid Agonists; Exploratory Behavior; Hyperalgesia; Injections, Spinal; Mice; Mice, Inbred C57BL; Mice, Knockout; N-Methylaspartate; Pain Measurement; Prazosin; Quinoxalines; Receptors, Adrenergic, alpha-2

2009
Ketamine activates the L-arginine/Nitric oxide/cyclic guanosine monophosphate pathway to induce peripheral antinociception in rats.
    Anesthesia and analgesia, 2011, Volume: 113, Issue:5

    Topics: Analgesia; Anesthetics, Dissociative; Animals; Arginine; Cyclic AMP; Dinoprostone; Drug Synergism; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Guanylate Cyclase; Hyperalgesia; Ketamine; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Oxadiazoles; Pain; Peripheral Nervous System Diseases; Quinoxalines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Signal Transduction

2011
Participation of the NO/cGMP/K+ATP pathway in the antinociception induced by Walker tumor bearing in rats.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2012, Volume: 45, Issue:6

    Topics: Analgesics; Animals; Arginine; Carcinoma 256, Walker; Carrageenan; Cyclic GMP; Dinoprostone; Hyperalgesia; KATP Channels; Male; Nitric Oxide; Nociception; Oxadiazoles; Pain Measurement; Pain Threshold; Quinoxalines; Rats; Rats, Wistar; Signal Transduction

2012
Inflammatory sensitization of nociceptors depends on activation of NMDA receptors in DRG satellite cells.
    Proceedings of the National Academy of Sciences of the United States of America, 2014, Dec-23, Volume: 111, Issue:51

    Topics: 2-Amino-5-phosphonovalerate; Animals; Dinoprostone; Ganglia, Spinal; Hyperalgesia; Nociceptors; Quinoxalines; Rats; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Satellite Cells, Perineuronal

2014
Effects of prostaglandin E2 on synaptic transmission in the rat spinal trigeminal subnucleus caudalis.
    Brain research, 2015, Nov-02, Volume: 1625

    Topics: Animals; Biphenyl Compounds; Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide; Dinoprostone; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; In Vitro Techniques; Male; Neurons; Patch-Clamp Techniques; Picrotoxin; Prostaglandin Antagonists; Quinoxalines; Rats; Rats, Wistar; Reaction Time; Synaptic Transmission; Trigeminal Nucleus, Spinal

2015
Orally Bioavailable Quinoxaline Inhibitors of 15-Prostaglandin Dehydrogenase (15-PGDH) Promote Tissue Repair and Regeneration.
    Journal of medicinal chemistry, 2022, 11-24, Volume: 65, Issue:22

    Topics: Animals; Colitis, Ulcerative; Dinoprostone; Hydroxyprostaglandin Dehydrogenases; Mice; Quinoxalines

2022